Cure research: open access publications
29 June 2018. Related: Cure-related research, On the web.
2018
US community call for coalition for long-term survivors
29 June 2018. Related: On the web.
29 June 2018: vol 19 no 11
29 June 2018. Related: PDFs.
08 June 2018: vol 19 no 10
8 June 2018. Related: PDFs.
08 June 2018: vol 19 no 10: DTG alert and PK reports
8 June 2018. Related: Editorial.
Introduction to ART (May 2018)
8 June 2018. Related: Supplements.
BHIVA statement on potential safety signal in infants born to women conceiving on dolutegravir
8 June 2018. Related: Treatment alerts, Pregnancy, Side effects.
ViiV Dear Doctor letter: Neural tube defects reported in infants born to women exposed to dolutegravir at the time of conception
8 June 2018. Related: Treatment alerts, Pregnancy.
19th International Workshop on Clinical Pharmacology, 22–24 May 2018, Baltimore
8 June 2018. Related: Conference reports.
Dolutegravir 50 mg twice daily sufficient with rifampicin but levels reduced significantly with 100 mg once daily
8 June 2018. Related: Conference reports, PK and drug interactions, TB coinfection.
Vaginal ring reduces efavirenz but not atazanavir exposures
8 June 2018. Related: Conference reports, PK and drug interactions.
Dispersible paediatric versions of dolutegravir provide higher bioavailability than immediate release formulations
8 June 2018. Related: Conference reports, Paediatric care.
EMA approves dolutegravir/rilpivirine (Juluca) in Europe as dual-therapy HIV switch option
8 June 2018. Related: Antiretrovirals.
Broad PrEP access in Australia reduces HIV infections even with reduced condom use by people not on PrEP
8 June 2018. Related: HIV prevention and transmission.
Boosted darunavir is associated with higher cardiovascular risk in D:A:D study, but not atazanavir
8 June 2018. Related: Side effects, Lipodystrophy and metabolic complications.
Online database of more than 200 studies on HIV cure research
8 June 2018. Related: Cure-related research, On the web.
Community survey on treatment interruptions (ATIs) in cure research
8 June 2018. Related: Cure-related research, On the web.
Webcasts on PrEP and women
8 June 2018. Related: HIV prevention and transmission, On the web.
Sexual identity and HIV
8 June 2018. Related: On the web.
Modern ART in Africa: new resources
8 June 2018. Related: On the web.
21 May 2018: vol 19 no 9: DTG Alert and BHIVA/BASHH reports
21 May 2018. Related: Editorial.
Potential safety signal for dolutegravir from the time of conception
21 May 2018. Related: Treatment alerts, Pregnancy.
Fourth Joint Conference of BHIVA/BASHH (4th BHIVA/BASHH)
21 May 2018. Related: Conference reports.
Low PEP and PrEP awareness among trans people in London and their partners
21 May 2018. Related: Conference reports, HIV prevention and transmission.
Low awareness of PrEP in BME communities in Leeds but high interest in use
21 May 2018. Related: Conference reports, HIV prevention and transmission.
Younger people living with HIV more likely to have a positive self image
21 May 2018. Related: Conference reports, Other news.
Zero or negligible risks of HIV, HBV or HCV transmission by biting or spitting
21 May 2018. Related: Conference reports, HIV prevention and transmission.
UK-CAB community representation on guideline panels and research studies
21 May 2018. Related: Conference reports, Treatment advocacy.
Phase 3 registrational data is not sufficient for roll-out of new ARVs in low- and middle-income countries
21 May 2018. Related: Treatment access.
Generic manufacturers from South Africa and South Korea join Medicine Patent Pool (MPP)
21 May 2018. Related: Treatment access.
WHO releases first list for essential diagnostics
21 May 2018. Related: Treatment access.
Dolutegravir in pregnancy: early data reassuring but ongoing surveillance is still essential
21 May 2018. Related: Pregnancy.
FDA guidance for developing paediatric ARVs: online for comment (2018)
21 May 2018. Related: Paediatric care, Guidelines.
US study tracks kidney transplant results from HIV positive donors
21 May 2018. Related: Coinfections and complications.
Campaign forces Government U-turn on linking NHS data to immigration service
21 May 2018. Related: Treatment access, Other news.
St Stephen’s AIDS Trust to close after 30 years of HIV research
21 May 2018. Related: Other news.
New online animation of HIV lifecycle
21 May 2018. Related: Basic science and immunology, On the web.
21 May 2018: vol 19 no 9
21 May 2018. Related: PDFs.
01 May 2018: vol 19 no 8: BHIVA/BASHH reports
1 May 2018. Related: Editorial.
Fourth Joint Conference of BHIVA/BASHH (4th BHIVA/BASHH)
1 May 2018. Related: Conference reports.
Almost 1 in 8 people with symptoms turned away from sexual health clinics in SE London: 40% are under 25 and 6% under 18 years old
1 May 2018. Related: Conference reports, Treatment access, Women's health, Pregnancy, HIV prevention and transmission.
A new framework for best HIV care: BHIVA Standards of Care revised and updated (2018)
1 May 2018. Related: Conference reports, Guidelines.
Key changes to upcoming UK HIV pregnancy guidelines (2018)
1 May 2018. Related: Conference reports, Pregnancy, Guidelines.
Pregnancy studies at 4th Joint BHIVA/BASHH Conference
1 May 2018. Related: Conference reports, Pregnancy.
Meta-analysis of TAF vs TDF in boosted vs unboosted regimens
1 May 2018. Related: Conference reports, Antiretrovirals.
Meta-analysis of dolutegravir in naive, experienced and switch studies
1 May 2018. Related: Conference reports, Antiretrovirals.
Not claptrap: kissing as the strongest route for oral gonorrhoea
1 May 2018. Related: Conference reports, Coinfections and complications.
Rapid PrEP uptake in Scotland exceeds expectations
1 May 2018. Related: Conference reports, HIV prevention and transmission.
Drug cost savings from routine use of generic ARVs: safety and efficacy in practice
1 May 2018. Related: Conference reports, Antiretrovirals, Treatment access.
Continued demands to stop NHS Digital linking medical records to deportation services
1 May 2018. Related: Treatment access, Other news.
01 May 2018: vol 19 no 8
1 May 2018. Related: PDFs.
16 April 2018: vol 19 no 7: CROI 2018 part 3
16 April 2018. Related: Editorial.
In Memory: Professor David Cooper
16 April 2018. Related: In memory.
CROI 2018: third reports
16 April 2018. Related: Conference reports.
No increased risk of IRIS in people with low CD4 counts receiving raltegravir in the REALITY trial
16 April 2018. Related: Conference reports, Coinfections and complications.
Isoniazid preventive TB therapy in pregnancy and postpartum: recommendations now need to be re-evaluated
16 April 2018. Related: Conference reports, Women's health, Pregnancy, TB coinfection.
Efavirenz might decrease effectiveness of the vaginal contraceptive ring
16 April 2018. Related: Conference reports, Pregnancy, PK and drug interactions.
Switch to TAF appears safe and effective in adolescents: similar PK to adults
16 April 2018. Related: Conference reports, Paediatric care.
Doubling raltegravir dose could overcome interaction with rifampicin in children aged 2 to 6
16 April 2018. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
Twice-daily bictegravir does not overcome drug interaction with rifampicin
16 April 2018. Related: Conference reports, PK and drug interactions, TB coinfection.
Reducing risk of myocardial infarction (MI) in HIV positive people
16 April 2018. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications, Coinfections and complications.
M184V mutation associated with increased risk of viral blip but not viral failure with 3TC-based dual therapy
16 April 2018. Related: Conference reports, Treatment strategies, Drug resistance.
PrEP engagement workshops
16 April 2018. Related: HIV prevention and transmission.
Legal Aide – an app if arrested for personal drug possession
16 April 2018. Related: On the web.
IAS reviews
16 April 2018. Related: On the web.